Secondary malignant neoplasm of peritoneum
|
disease |
|
Neoplastic Process
|
58
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Malignant neoplasm of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2667
|
277
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant Childhood Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
179
|
34
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Childhood Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
771
|
25
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant neoplasm of brain
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
294
|
16
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Esophageal carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1287
|
272
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Migraine Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
512
|
264
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Small cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
972
|
125
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Depressive Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
421
|
120
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
POEMS Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
26
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
T-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
485
|
24
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lymphoma, Large-Cell, Follicular
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
153
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lentivirus Infections
|
group |
Infections
|
Disease or Syndrome
|
88
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Fibromatosis, Aggressive
|
disease |
Neoplasms
|
Neoplastic Process
|
84
|
12
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.010 |
None |
1.000 |
1 |
|
1989 |
1989 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
< 0.001 |
1 |
|
2011 |
2011 |
Aortic Aneurysm, Abdominal
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
586
|
90
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Parathyroid hyperplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
37
|
1
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Deficiency of steroid 21-monooxygenase
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Congenital Abnormality
|
54
|
26
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Freeman-Sheldon syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
26
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Parathyroid Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
133
|
12
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Systemic Inflammatory Response Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
185
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1348
|
204
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
MYOCARDITIS, ACTIVE
|
disease |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |